Leukaemia Foundation

Leukaemia, Lymphoma, Myeloma & Related Blood Disorders.

Change Your Location:

Professor Geoff Hill

MBChB MD FRACP FRCPA

Professor Hill obtained his undergraduate and medical degree at the University of Auckland. His specialist haematology training was undertaken in Christchurch, NZ, at The Dana Farber Cancer Institute, and Harvard Medical School in Boston.

His doctoral thesis is based on work at Harvard University where he characterised the mechanisms by which BMT conditioning influences acute GVHD. This work was a prelude to studies of low intensity conditioning and new growth factors in myeloablative transplantation which have now moved through successful phase III clinical trials in the USA and onto the market.

Professor Geoff Hill is a NH&MRC Practitioner Fellow with his own laboratory at the Queensland Institute of Medical Research. His focus is on the interactions between growth factors, antigen presenting cells and NKT/regulatory T-cells during transplantation. This has led to the study of new growth factors for the mobilisation of hematopoietic stem cells to limit GVHD and improve leukemia clearance after transplantation. Professor Hill was named the 2005 ‘Queenslander of the Year’ for his basic research and clinical work in the transplant field.